theMednet - Would you offer Gemcitabine/Cisplatin (or other platinum-based regimens) for metastatic pancreatic cancer harboring somatic ATM mutations?

Topics: Gastrointestinal Cancers • Medical Oncology • Pancreatic Cancer

Would you offer Gemcitabine/Cisplatin (or other platinum-based regimens) for metastatic pancreatic cancer harboring somatic ATM mutations?

NCCN indicates only BRCA1/2 and PALB2 mutations